Skip to main content

BPC-157 & TB-500 & GHK-Cu (Triple Healing Stack) Dosage Guide

40/100 confidence

Complete guide to BPC-157 & TB-500 & GHK-Cu (Triple Healing Stack) dosing protocols, administration methods, and safety considerations for research purposes.

NOT Medical Advice

The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.

Dosage Overview

Dose Range

250 mcg - 500 mcg

Route

multiple

Frequency

2x daily

Cycle Length

4-8 weeks

Reconstitution

Vial Size

10 mg

BAC Water

2 ml

Concentration

5,000 mcg/ml

Detailed Dosage Information

Typical protocol: BPC-157 250-500mcg daily, TB-500 2-2.5mg twice weekly, GHK-Cu 1-2mg daily or applied topically for skin applications.

Administration Method

BPC-157 and TB-500 via subcutaneous injection. GHK-Cu can be injected subcutaneously or used topically depending on the target area. Systemic and local administration may be combined.

Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.

Quick Calculator

Concentration: 5,000 mcg/ml

Volume to inject: 0.05 ml

Syringe units (U-100): 5.0 units

Pre-filled with BPC-157 & TB-500 & GHK-Cu (Triple Healing Stack) defaults. Adjust values as needed.

Open Full Calculator →

Research Backing

Preclinical synergy studies (BPC \+ TB-500); BPC-157 Phase I human pilots (oral/IV safe); TB-4 animal wound models; GHK-Cu multiple wound-healing RCTs and cosmetic trials (PMC6073405, PMC reviews). Stack protocols widely referenced in regenerative research literature.

Side Effects to Monitor

Generally well-tolerated. Possible injection site irritation, mild fatigue, or temporary skin discoloration with GHK-Cu.

Safety Considerations & Risks

Limited human data on this specific combination. Individual peptides not FDA approved. Copper peptides may not be suitable for those with copper metabolism disorders.